{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:30:24Z","timestamp":1760016624552,"version":"3.40.5"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circ: Cardiovascular Quality and Outcomes"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Quality of care measures are vital tools to assess processes of care within and between health care systems. The 2020 American College of Cardiology\/AHA performance measures for heart failure provide a new set of such measures. We evaluated the achievement of these and other performance measures within the Veterans Affairs hospital system in a contemporary cohort of patients hospitalized for heart failure.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Hospital discharges from January 2010 to February 2021 with a primary diagnosis of heart failure (n=289\u2009810) were evaluated. Adherence to each measure was determined using the measure\u2019s stated definition and by site.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Among patients with reduced ejection fraction (53.0%), beta blocker use was high (89.0%), ACE (angiotensin-converting enzyme) inhibitor, angiotensin receptor blocker, or angiotensin receptor-neprilysin inhibitor (ARNI) use decreased over time (75.3% in 2010, 55.8% in 2020), and hydralazine\/nitrate use in eligible Black patients (19.3%) was low. While 68.1% were eligible for ARNI, only 6.0% received them, reaching 17.2% by 2020. Mineralocorticoid receptor antagonists were used in 49.3% of those eligible; laboratory testing 7 days after their initiation was 73.0%, detecting hyperkalemia in 2.2%, although it occurred in 13.7% by 90 days. Achievement of \u226550% target dose was low (beta blocker 45.9%, ACE inhibitor\/angiotensin receptor blocker 31.6%, ARNI 19.0%) and for ACE inhibitor\/angiotensin receptor blocker\/ARNI, decreased over time. Discharge appointments were 56.2% at 7 days and 78.8% at 14 days. Cardiac rehabilitation referral was low (10.5%) but increased. There were significant site-level differences, particularly for hydralazine, ARNI, devices, and cardiac rehabilitation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Important inpatient quality of care measures can be readily measured across the Veterans Administration health care system from electronic health records. Treatment gaps and site-level differences persisted into the contemporary era and will likely be exacerbated as newer treatments are added to this complex baseline. These measures and methods also offer the opportunity to target global, local, and individual processes of care for innovative quality improvement initiatives.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/circoutcomes.122.008936","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T18:17:40Z","timestamp":1665685060000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Inpatient Quality-of-Care Measures for Heart Failure: Treatment Gaps and Opportunities in the Contemporary Era"],"prefix":"10.1161","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3592-3764","authenticated-orcid":true,"given":"Alberta L.","family":"Warner","sequence":"first","affiliation":[{"name":"Department of Cardiology (A.L.W., Z.G.), Veterans Affairs Greater Los Angeles Healthcare System, CA."},{"name":"David Geffen School of Medicine at UCLA (A.L.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyun","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (L.L., C.A.J.), Veterans Affairs Greater Los Angeles Healthcare System, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zunera","family":"Ghaznavi","sequence":"additional","affiliation":[{"name":"Department of Cardiology (A.L.W., Z.G.), Veterans Affairs Greater Los Angeles Healthcare System, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5274-7251","authenticated-orcid":true,"given":"Cynthia A.","family":"Jackevicius","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (L.L., C.A.J.), Veterans Affairs Greater Los Angeles Healthcare System, CA."},{"name":"Department of Pharmacy Practice and Administration, College of Pharmacy, Western University of Health Sciences, Pomona, CA (C.A.J.)."},{"name":"ICES, Toronto, Canada (C.A.J.)."},{"name":"Institute of Health Policy, Management and Evaluation, University of Toronto, Canada (C.A.J.)."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e31829e8776"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000509"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e3182507bec"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.13.1469"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.14.1493"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/HCQ.0000000000000099"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-200206000-00011"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0278"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e3181f53575"},{"key":"e_1_3_3_11_2","unstructured":"VA Health Services Research and Development QUERI Implementation Projects Chronic Heart Failure. Accessed March 22 2022. https:\/\/www.hsrd.research.va.gov\/research\/queri_studies.cfm?center=Chronic%20Heart%20Failure"},{"key":"e_1_3_3_12_2","unstructured":"VA Informatics and Computing Infrastructure (VINCI) VA HSR HIR 08-204 U.S. Department of Veterans Affairs (2008). https:\/\/www.hsrd.research.va.gov\/for_researchers\/vinci\/ Accessed March 21 2022."},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-017-0580-8"},{"volume-title":"Sacubitril\/valsartan, Criteria for Use","year":"2015","key":"e_1_3_3_14_2","unstructured":"Sacubitril\/valsartan, Criteria for Use. Pharmacy Benefits Management Services, Medical Advisory Panel and VISN Pharmacist Executives, Veterans Health Administration, Department of Veterans Affairs; September 2015. (Archived Sept 2016)."},{"volume-title":"Sacubitril\/valsartan, Criteria for Use","year":"2019","key":"e_1_3_3_15_2","unstructured":"Sacubitril\/valsartan, Criteria for Use. Pharmacy Benefits Management Services, Medical Advisory Panel and VISN Pharmacist Executives, Veterans Health Administration, Department of Veterans Affairs; May 2019 (Archived March 2020)."},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-020-09979-z"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2283"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.04.070"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.510"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.4585"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015042"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2020.05.013"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2021.05.015"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjco.2020.03.015"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.027773"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2016.1724"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004745"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908655"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2021.02.006"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000492"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.116.003194"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2018.06.011"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.110.959122"},{"key":"e_1_3_3_34_2","unstructured":"GWTG-HF IQVIA Registry. Accessed May 27 2022. https:\/\/www.heart.org\/-\/media\/Files\/Professional\/Quality-Improvement\/Get-With-the-Guidelines\/Get-With-The-Guidelines-HF\/Clinical-Tools\/HF-Full-CRF-Aug-2021.pdf"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1701257"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-017-0627-z"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2021.06.011"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/ehjacc\/zuab042"}],"container-title":["Circulation: Cardiovascular Quality and Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCOUTCOMES.122.008936","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T03:36:09Z","timestamp":1715571369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCOUTCOMES.122.008936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10.1161\/CIRCOUTCOMES.122.008936"],"URL":"https:\/\/doi.org\/10.1161\/circoutcomes.122.008936","relation":{},"ISSN":["1941-7713","1941-7705"],"issn-type":[{"type":"print","value":"1941-7713"},{"type":"electronic","value":"1941-7705"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"2022-01-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}